Bioprocessing Completes New Biomanufacturing Facility Move
Complete the form below to unlock access to ALL audio articles.
Bioprocessing, Inc. has announced that it has recently moved into a new bulk biologics manufacturing facility in Portland, Maine.
Construction began in December of 2005 and the facility and is now operationally complete.
Operations at the site have an initial workforce of 13 employees. The facility contains five cell culture suites that enable Bioprocessing, Inc. to expand from its previous facility in Scarborough, Maine.
The new manufacturing facility supports a five fold increased production capacity for its bioreactor produced products and services.
"The ability to expand our cell culture expertise is key in our participation in the development and manufacture of new biomarkers and preclinical biologics," said Gary Goodrich, President of Bioprocessing, Inc.
"This new facility is a vital part of our commitment to provide critical tumor marker raw material products and services to the diagnostic, research and biopharmaceutical industries."
"We are particularly excited about operating an eco-friendly and highly energy efficient building. A low environmental impact and a safe, comfortable workplace are important parts of our company goals."
"We have tried to make our new building a reflection of our technology," said Goodrich. "Highly efficient and state of the art."
